Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Published:2019-10 Issue:10 Volume:19 Page:1091-1100
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Abraham Sonya,Juel Helene B,Bang Peter,Cheeseman Hannah M,Dohn Rebecca B,Cole Tom,Kristiansen Max P,Korsholm Karen S,Lewis David,Olsen Anja W,McFarlane Leon R,Day Suzanne,Knudsen Sara,Moen Kjersti,Ruhwald Morten,Kromann Ingrid,Andersen Peter,Shattock Robin J,Follmann Frank

Funder

European Commission

The Innovation Fund Denmark

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting;Newman;PLoS One,2015

2. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark;Davies;Lancet Infect Dis,2016

3. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet,2017

4. Pathogenesis of Chlamydia induced pelvic inflammatory disease;Cohen;Sex Transm Infect,1999

5. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection;Ng;Cochrane Database Syst Rev,2011

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chlamydia infections;Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant;2025

2. Advances in the design and delivery of RNA vaccines for infectious diseases;Advanced Drug Delivery Reviews;2024-10

3. Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice;Vaccines;2024-08-22

4. Chlamydia in pigs: intriguing bacteria associated with sub-clinical carriage and clinical disease, and with zoonotic potential;Frontiers in Cell and Developmental Biology;2024-08-14

5. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial;The Lancet Infectious Diseases;2024-08